Panel Discussion | The Next Wave of Innovation in Interventional Cardiology | Coronary DCBs, Innovative Left-Atrial-Appendage-Closure, Imaging, Left Atrial Shunts, and Novel Heart Failure Management Technologies - The CMO roundtable

Tuesday, March 11, 2025

10:30 AM - 10:50 AM ET

Panel Moderator(s)

Lawrence Biegelsen, MBA

Managing Director Medical Supplies & Devices
Wells Fargo
Short Hills, New Jersey, United States

No relationships to disclose
Rick Wise, CFA

Research Analyst
Stifel
New York, New York, United States

No relationships to disclose

Panel Discussant(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure information not submitted.
Dominic Allocco, MD, MS

Associate Chief Medical Officer
Shockwave/Johnson & Johnson, Minnesota, United States

Disclosure information not submitted.
Steven R. Bailey, MD, MSCAI

Professor of Medicine
LSU Health Shreveport
San Antonio, Texas, United States

No relationships to disclose
Rafael Cavalcante, MD, PhD

Vice President, Medical Affairs
Boston Scientific
Newton, Massachusetts, United States

No relationships to disclose
Samuel Conaway, MBA

President Cardiology Sales
Boston Scientific Corporation

No relationships to disclose
Haim Danenberg, MD

Head of interventional cardiology
Wolfson Medical Center
Holon, Israel

Disclosure(s): Abbott Cardiovascular Systems: clinical proctor (Ongoing)
Manish Doshi, PhD

Founder and Managing Director
Concept Medical, Florida, United States

No relationships to disclose
Jeffrey J. Popma, MD

CRF
Newton, Massachusetts, United States

Disclosure information not submitted.
Patrick W. Serruys, MD, PhD

Professor of Medical Intervention & Innovation
University of Galway, Ireland

Disclosure information not submitted.
Charles A. Simonton, MD, FACC, FSCAI

EVP Chief Medical Officer
Abiomed a Johnson + Johnson MedTech Company
Charlotte, North Carolina, United States

No relationships to disclose
JW

Jason Weidman

No relationships to disclose

Disclosure(s):

Lawrence Biegelsen, MBA: No financial relationships to disclose

Rick Wise, CFA: No financial relationships to disclose

William T. Abraham, MD: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)

Dominic Allocco, MD, MS: Boston Scientific: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave/Johnson&Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Steven R. Bailey, MD, MSCAI: No financial relationships to disclose

Samuel Conaway, MBA: No financial relationships to disclose

Haim Danenberg, MD: Abbott Cardiovascular Systems: clinical proctor (Ongoing)

Manish Doshi, PhD: Concept Medical: Employee (Ongoing), Stock-privately held company (Ongoing)

Jeffrey J. Popma, MD: Medtronic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Patrick W. Serruys, MD, PhD: Merillife Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)

Charles A. Simonton, MD, FACC, FSCAI: Johnson and Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing)